APT Medical Inc (688617) — Capital Reinvestment Ratio

Latest as of December 2025: 0.18x

APT Medical Inc (688617) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥294.68 Million) in capital expenditures (CN¥52.10 Million). See APT Medical Inc balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.18x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥294.68 Million
CNY

Capital Expenditures

CN¥52.10 Million
CNY

Data as of

Dec 2025
Most recent filing

APT Medical Inc Capital Reinvestment Ratio (2017–2025)

This chart tracks APT Medical Inc's Capital Reinvestment Ratio across 9 annual periods. Check APT Medical Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for APT Medical Inc (2017–2025)

Year-by-year Capital Reinvestment Ratio for APT Medical Inc from 2017 to 2025. For live market cap and broader valuation context, see APT Medical Inc market cap and net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.29x CN¥975.30 Million CN¥285.59 Million ▼ -66.5%
2024 0.87x CN¥743.39 Million CN¥650.24 Million ▲ +198.3%
2023 0.29x CN¥689.06 Million CN¥202.03 Million ▼ -24.8%
2022 0.39x CN¥367.46 Million CN¥143.21 Million ▼ -57.8%
2021 0.92x CN¥181.39 Million CN¥167.38 Million ▲ +209.5%
2020 0.30x CN¥148.24 Million CN¥44.20 Million ▼ -75.8%
2019 1.23x CN¥54.90 Million CN¥67.56 Million ▼ -28.8%
2018 1.73x CN¥18.63 Million CN¥32.20 Million ▼ -11.7%
2017 1.96x CN¥12.91 Million CN¥25.26 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow